Compound for prevention or treatment of kidney disease
AssigneeOncocross Co., Ltd.
InventorYi Rang KIM
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a use of (R)-4-{(R)-1-[7-(3,4,5-trimethoxy-phenyl)-[1,6] naphthyridin-5-yloxy]-ethyl}pyrrolidin-2-one in treating kidney disease. According to the present disclosure, (R)-4-{(R)-1-[7-(3,4,5-trimethoxy-phenyl)-[1,6] naphthyridin-5-yloxy]-ethyl}pyrrolidin-2-one of the present disclosure palliates clinical symptoms and alleviates renal failure and renal injury through reduction of blood glucose levels and insulin resistance in diabetic nephrosis animal models. Thus, the compound may be advantageously applied to a use for preventing or treating kidney diseases, especially diabetic renal diseases.
Claims8
1-14. (canceled).
A method for preventing or treating a kidney disease, comprising administering to a subject in need thereof (R)-4-{(R)-1-[7-(3,4,5-trimethoxy-phenyl)-[1,6] naphthyridin-5-yloxy]-ethyl}pyrrolidin-2-one or a pharmaceutically acceptable salt thereof as an active ingredient.
Dependencies are inferred from the claim text.